Zions Bancorporation, National Association’s Avidity Biosciences RNAM Stock Holding History

Zions Bancorporation, National Association’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$721	–	1575
2025 Q4	$721	Buy	+10	New	+$646	﹤0.01%	1163

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Zions Bancorporation, National Association's RNAM Position: Q1 2026 in Review

Zions Bancorporation, National Association sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 10 shares — an estimated $721 sold.

Zions Bancorporation, National Association first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $721 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Zions Bancorporation, National Association reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Zions Bancorporation, National Association sold 10 Avidity Biosciences shares in Q1 2026, an estimated $721.
Zions Bancorporation, National Association first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Zions Bancorporation, National Association's Avidity Biosciences position peaked at $721 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q1 2026, filed 8 May 2026.